Intracellular Construction of Cathepsin B‐Guided Gadolinium Nanoparticles for Enhanced T 2 ‐Weighted MR Tumor Imaging
Small · 2023-07 · 19 (29)
DOI: 10.1002/smll.202300015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 08.04.2023. Verfasst von Mengxing Wei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026, China. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Magnetic resonance imaging (MRI) is a superior and noninvasive imaging technique with unlimited tissue penetration depth and superb spatiotemporal resolution, however, using intracellular self‐assembly of Gd‐containing nanoparticles to enhance the T 2 ‐weighted MR contrast of cancer cells in vivo for precise tumor MRI is rarely reported. The lysosomal cysteine protease cathepsin B (CTSB) is regarded as an attractive biomarker for the early diagnosis of cancers and metastasis. Herein, taking advantage of a biocompatible condensation reaction, a “smart” Gd‐based CTSB‐responsive small molecular contrast agent VC‐Gd‐CBT is developed, which can self‐assemble into large intracellular Gd‐containing nanoparticles by glutathione reduction and CTSB cleavage to enhance the T 2 ‐weighted MR contrast of CTSB‐overexpressing MDA‐MB‐231 cells at 9.4 T. In vivo T 2 ‐weighted MRI studies using MDA‐MB‐231 murine xenografts show that the T 2 ‐weighted MR contrast change of tumors in VC‐Gd‐CBT‐injected mice is distinctly larger than the mice injected with the commercial agent gadopentetate dimeglumine, or co‐injected with CTSB inhibitor and VC‐Gd‐CBT, indicating that the accumulation of self‐assembled Gd‐containing nanoparticles at tumor sites effectively enhances the T 2 ‐weighted MR tumor imaging. Hence, this CTSB‐targeted small molecule VC‐Gd‐CBT has the potential to be employed as a T 2 contrast agent for the clinical diagnosis of cancers at an early stage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026, China.
- Anhui Provincial Key Laboratory of High Magnetic Resonance Image, High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, China.
- Division of Life Sciences and Medicine, Joint Center for Biological Analytical Chemistry, University of Science and Technology of China, Hefei, Anhui, 230026, China.
- State Key Laboratory of Bioelectronics, School of Biological Sciences and Medical Engineering, Southeast University, Nanjing, Jiangsu, 210096, China.
ORCID-Profile: Changlin Tian, Gaolin Liang, Yue Yuan
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wei, M., Wang, L., Wang, Y., Zhang, T., Wang, C., Wu, C., Tian, C., Liang, G., & Yuan, Y. (2023). Intracellular Construction of Cathepsin B‐Guided Gadolinium Nanoparticles for Enhanced T 2 ‐Weighted MR Tumor Imaging. Small, 19(29). https://doi.org/10.1002/smll.202300015
Vancouver
Wei M, Wang L, Wang Y, Zhang T, Wang C, Wu C, et al. Intracellular Construction of Cathepsin B‐Guided Gadolinium Nanoparticles for Enhanced T 2 ‐Weighted MR Tumor Imaging. Small. 2023;19(29). doi:10.1002/smll.202300015
BibTeX
@article{Wei2023,
author = {Wei, Mengxing and Wang, Lulu and Wang, Yanfang and Zhang, Tong and Wang, Chenchen and Wu, Chengfan and Tian, Changlin and Liang, Gaolin and Yuan, Yue},
title = {Intracellular Construction of Cathepsin B‐Guided Gadolinium Nanoparticles for Enhanced T 2 ‐Weighted MR Tumor Imaging},
journal = {Small},
year = {2023},
volume = {19},
number = {29},
doi = {10.1002/smll.202300015}
}
EUVIMED